Treatment of Patients With Type 2 Diabetes With an Interleukin-1 Antagonist

NCT00303394 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
72
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Zurich

Collaborators